Australia's most trusted
source of pharma news
Posted 26 April 2024 AM
Medicines Australia's CEO, Liz de Somer, has again called on the Federal Government to lower the discount rate for vaccines with a new report showing vaccination programs deliver 19 times return on investment.
The first-of-its-kind benefit-cost analysis of adult immunisation programs by the Office of Health Economics and commissioned by the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), looked at programs against influenza, pneumococcal disease, herpes zoster, and respiratory syntical virus (RSV) across 10 countries, including Australia.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.